Home/Filings/4/0001773782-19-000002
4//SEC Filing

Krex Brian 4

Accession 0001773782-19-000002

CIK 0001273636other

Filed

Apr 17, 8:00 PM ET

Accepted

Apr 18, 4:09 PM ET

Size

5.5 KB

Accession

0001773782-19-000002

Insider Transaction Report

Form 4
Period: 2019-03-25
Krex Brian
General Counsel
Transactions
  • Award

    Stock Option (right to buy)

    2019-03-25+125,000125,000 total
    Exercise: $4.20Exp: 2029-03-25Common Stock (125,000 underlying)
Footnotes (1)
  • [F1]Opton becomes exercisable for 25% of the underlying shares on the first anniversary of the grant date, and thereafter becomes exercisable for the remaining underlying shares, in equal monthly installments over three years, reuslting in the option being exercisable for 100% of the underlying shares on the fourth anniversary of the grant date.

Issuer

APPLIED GENETIC TECHNOLOGIES CORP

CIK 0001273636

Entity typeother

Related Parties

1
  • filerCIK 0001773782

Filing Metadata

Form type
4
Filed
Apr 17, 8:00 PM ET
Accepted
Apr 18, 4:09 PM ET
Size
5.5 KB